IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank88
5Y CAGR-21.3%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
-21.3%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202570.78%
2024-113.82%
2023-29.77%
2022-55.11%
2021-206.28%
2020235.17%
2019-38.66%
2018-109.77%
20170.00%